Seeking Alpha

Corcept Therapeutics (CORT), a specialty drug company that hasn’t generated revenue since...

Corcept Therapeutics (CORT), a specialty drug company that hasn’t generated revenue since 2009, wins FDA approval for its Korlym treatment that uses the active ingredient of the abortion pill RU-486 to treat Cushing’s Syndrome. Shares +42.5% after a trading halt.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)